Publications by authors named "S Stamova"

IL-32 expression is important for pathogen clearance but detrimental in chronic inflammation, autoimmunity, and cancer. T cells are major IL-32 producers in these diseases and key mediators of pathogen and tumor elimination but also autoimmune destruction. However, their contribution to IL-32 biology during immune responses is hardly understood due to several isoforms with divergent inflammatory properties.

View Article and Find Full Text PDF

Cancer immunotherapy is a pillar of clinical oncology but only achieves long-term remissions in a minority of cases. In this issue, van Elsas et al. show that effective immunotherapy requires a series of processes orchestrated by CD8 T cells that result in the recruitment and local activation of M1-like macrophages.

View Article and Find Full Text PDF
Article Synopsis
  • Glioblastoma (GB) IDH-wildtype is a highly aggressive brain tumor that shows significant resistance to immunotherapy, with the translocator protein 18 kDa (TSPO) playing a key role in this process.* -
  • TSPO expression in GB cells correlates with immune infiltration and resistance to T cell-mediated killing, as it regulates apoptosis pathways and is upregulated in response to cytokines from T cells.* -
  • Targeting TSPO may enhance the effectiveness of immunotherapy for GB by overcoming intrinsic resistance mechanisms and improving the sensitivity of cancer cells to immune attacks.*
View Article and Find Full Text PDF

Background: Cancer immunotherapeutic strategies showed unprecedented results in the clinic. However, many patients do not respond to immuno-oncological treatments due to the occurrence of a plethora of immunological obstacles, including tumor intrinsic mechanisms of resistance to cytotoxic T-cell (TC) attack. Thus, a deeper understanding of these mechanisms is needed to develop successful immunotherapies.

View Article and Find Full Text PDF

Carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6), a cell surface receptor, is expressed on normal epithelial tissue and highly expressed in cancers of high unmet medical need, such as non-small cell lung, pancreatic, and colorectal cancer. CEACAM receptors undergo homo- and heterophilic interactions thereby regulating normal tissue homeostasis and angiogenesis, and in cancer, tumor invasion and metastasis. CEACAM6 expression on malignant plasma cells inhibits antitumor activity of T cells, and we hypothesize a similar function on epithelial cancer cells.

View Article and Find Full Text PDF